CCG
Schrodinger
The Cutting Edge Approaches to Drug Design (or CEA2DD) symposia are aimed primarily at Medicinal Chemists and other Drug Discovery Bioscientists eager to discover how modern, state-of-the-art methods can accelerate the process of drug design.
CEA2DD initially ran under the auspices of the Royal Society of Chemistry Molecular Modelling group for 5 years from 2001 to 2005 as a very successful series of meetings which were well supported by the community. Building on this success we have a renaissance, as the Molecular Graphics and Modelling Society takes the reinvigorated meeting under its metaphorical wing.
Talks are designed for the non-specialist and topics include, and are in no way limited to, target identification, virtual screening, informatics in lead optimisation, and in silico pharmacokinetic and ADMET profiling.
Worked examples will demonstrate the power and practicality of such methods.
|
CCG |
|
Schrodinger |